The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Follicular Lymphoma Treatment Global Market Report 2023, the follicular lymphoma treatment market is expected to show significant growth in the forecast period.

Key insights from the follicular lymphoma treatment market forecast include:

1. Market Size

The global follicular lymphoma treatment market is expected to grow from $2.59 billion in 2022 to $2.83 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The global follicular lymphoma treatment market size is expected to reach $3.8 billion in 2027 at a CAGR of 8.1%.

2. Major Driver

The increasing prevalence of follicular lymphoma is likely to drive the follicular lymphoma therapy market forward. According to the American Cancer Society, a US-based Voluntary organisation, non-Hodgkin lymphoma, a kind of indolent follicular lymphoma, will be the most common cancer in the US in January 2023, accounting for roughly 4% of all cancers. According to the American Cancer Society, NHL will be diagnosed in roughly 80,550 people (44,880 males and 35,670 women). Both adults and children are included. As a result, the increased occurrence of follicular lymphoma is propelling the follicular lymphoma therapy market forward.

View More On The Follicular Lymphoma Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/follicular-lymphoma-treatment-global-market-report#

3. Key Trend

Technological developments in follicular lymphoma diagnosis and therapy are a key trend-gaining potential in the follicular lymphoma treatment market. For example, Genentech Inc., a biotechnology company based in the United States, got FDA approval for Lunsumio, a new bispecific antibody for the treatment of relapsed or refractory follicular lymphoma, in December 2022. This antibody is a new class of fixed-duration cancer treatment immunotherapy, and it is a conveniently available and off-the-shelf treatment alternative that patients do not need to wait for. The FDA approval is based on positive results from the Lunsumio Phase II GO29781 research in people with extensively pretreated FL, particularly those who are at high risk of illness progression or who have been ineffective with past treatments.

4. Largest Region

North America was the largest region in the follicular lymphoma treatment market in 2022.

5. Major Players

Major players in the food diagnostics market are AbbVie Inc., Celgene Corporation, Bayer AG, Bristol Myers Squibb, F. Hoffmann-La Roche Ltd., Johnson and Johnson Services Inc., GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., EpiZyme Inc., Boehringer Ingelheim GmbH, CTI BioPharma Corp., Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., and Applied Molecular Genetics Inc.

Request A Sample Of The Global Follicular Lymphoma Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10758&type=smp

Key Follicular Lymphoma Treatment Market Segments
1) By Treatment: Monoclonal Antibodies, Targeted Therapy, Chemotherapy, Radiation Therapy, Stem Cell Transplant, Alkylating Agents, Nucleoside Analogues, Anthracycline Derivatives, Other Treatments
2) By Product Type: Tablets, Capsules, Injectables, Other Product Types
3) By Route of Administration: Oral, Parenteral, Other Route of Administration
4) By End Use: Hospitals, Oncology Centers, Ambulatory Care Centers, Academic Research Institutes, Other End Users

The Follicular Lymphoma Treatment Global Market Report 2023  provides an in-depth analysis on the follicular lymphoma treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the follicular lymphoma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
ENT Devices Global Market Report 2023
Nasal Splints Global Market Report 2023
Mucosal Atomization Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model